Showing results (381-390 of 1,152) with videos related to

Sort By:
Pageof 116
Melanoma Research|February 1, 1996
New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccinesM J Maeurer, W J Storkus, J M Kirkwood, et al.
Brain : a Journal of Neurology|September 22, 2009
When seeing outweighs feeling: a role for prefrontal cortex in passive control of negative affect in blindsightSilke Anders, Falk Eippert, Stefan Wiens, et al.
Nano Letters|July 27, 2016
Electronic Structure and Luminescence of Quasi-Freestanding MoS2 Nanopatches on Au(111)Nils Krane, Christian Lotze, Julia M Läger, et al.
Neuroscience Letters|August 24, 1999
Activation of human language processing brain regions after the presentation of random letter strings demonstrated with event-related functional magnetic resonance imagingF Jessen, M Erb, U Klose, et al.
Natural Immunity|April 1, 1995
Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEAM Maeurer, L Zitvogel, E Elder, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 13, 2012
Long-term prognosis of adult patients with isolated congenital left ventricular aneurysm or diverticulum and abnormal electrocardiogram patternsMarc-Alexander Ohlow, Bernward Lauer, Ulrich Lotze, et al.
International Journal of Molecular Sciences|December 11, 2022
Impaired Pain Processing at a Brainstem Level Is Involved in Maladaptive Neuroplasticity in Patients with Chronic Complex Regional Pain SyndromePauline Thoma, Nina Drämel, Matthias Grothe, et al.
Cancer Research|December 15, 1989
Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humansJ T Rubin, L J Elwood, S A Rosenberg, et al.
Autophagy|May 24, 2012
microRNA 30A promotes autophagy in response to cancer therapyYan Yu, Lizhi Cao, Liangchun Yang, et al.
The Cancer Journal From Scientific American|February 19, 1998
A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancerE E Vokes, R Figlin, H Hochster, et al.
Pageof 116